About Medpace Holdings, Inc. 
Medpace Holdings, Inc.
Miscellaneous
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Company Coordinates 
Company Details
5375 Medpace Way , CINCINNATI OH : 45227-1543
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 150 Schemes (38.17%)
Foreign Institutions
Held by 257 Foreign Institutions (21.74%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
DR. August Troendle
Chairman of the Board, President, Chief Executive Officer
Mr. Fred Davenport
Lead Independent Director
Mr. Brian Carley
Independent Director
Ms. Ashley Keating
Independent Director
Dr. Thomas King
Independent Director
Mr. Robert Kraft
Independent Director
Revenue and Profits:
Net Sales:
708 Million
(Quarterly Results - Dec 2025)
Net Profit:
135 Million
Miscellaneous
USD 12,910 Million (Small Cap)
37.00
NA
0.00%
-1.03
98.27%
28.12






